The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.27BCNY
340.77M · vs all stocks (USD)
Updated Oct 24, 2026
Revenue (TTM)
443.27MCNY
66.48M · vs all stocks (USD)
Updated Oct 24, 2026
Profit Margin
-10.85%
Updated Oct 24, 2026
Beta
0.1800x
vs all stocks
Updated Oct 24, 2026
52-Week Change
16.53%
vs all stocks
Updated Oct 24, 2026
Market Capitalization
2.27BCNY
340.77M · vs all stocks (USD)
Updated Oct 24, 2026
Enterprise Value
2.61BCNY
391.47M · vs all stocks (USD)
Updated Oct 24, 2026
Price to Sales (TTM)
5.13x
Updated Oct 24, 2026
Price to Book (MRQ)
2.95x
Updated Oct 24, 2026
Enterprise to Revenue
5.89x
Updated Oct 24, 2026
Enterprise to EBITDA
43.40x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 50.73×.Updated Oct 24, 2026
Gross Margin
28.65%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 24.48%.Updated Oct 24, 2026
Profit Margin
-10.85%
Updated Oct 24, 2026
Operating Margin
9.72%
Updated Oct 24, 2026
Return on Assets (TTM)
-0.50%
Updated Oct 24, 2026
Return on Equity (TTM)
-5.70%
Updated Oct 24, 2026
Revenue (TTM)
443.27MCNY
66.48M · vs all stocks (USD)
Updated Oct 24, 2026
Revenue per Share (TTM)
4.43CNYUpdated Oct 24, 2026
Quarterly Revenue Growth
19.10%
Updated Oct 24, 2026
Gross Profit (TTM)
108.50MCNY
16.27M · vs all stocks (USD)
Updated Oct 24, 2026
EBITDA (TTM)
51.45MCNY
7.72M · vs all stocks (USD)
Updated Oct 24, 2026
Net Income (TTM)
-48.10MCNY
-7.21M · vs all stocks (USD)
Updated Oct 24, 2026
Quarterly Earnings Growth (YoY)
58.38%
Updated Oct 24, 2026
Operating Cash Flow (TTM)
54.41MCNY
8.16M · vs all stocks (USD)
Updated Oct 24, 2026
Levered Free Cash Flow (TTM)
128.29MCNY
19.24M · vs all stocks (USD)
Updated Oct 24, 2026
5-Year Average Dividend Yield
0.58%
vs all stocks
Updated Oct 24, 2026
Payout Ratio
125.00%
Updated Oct 24, 2026
Minority Interest (Equity)
38.66MCNYFY2025 · Dec 31, 2025
Revenue
380.21MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
304.43MCNYFY2025 · Dec 31, 2025
Gross Profit
75.77MCNYFY2025 · Dec 31, 2025
Operating Income
-22.48MCNY
-3.37M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-77.53MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-7.60MCNYFY2025 · Dec 31, 2025
Net Income
-69.93MCNYFY2025 · Dec 31, 2025
EBIT
-54.97MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
51.45MCNYFY2025 · Dec 31, 2025
Research & Development
14.67MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
27.28MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
8.83MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
926.59KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
22.56MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.7000CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.7000CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
100.15MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
100.15MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-69.93MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-169.17KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-55.33MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-220.07MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
293.83MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-69.93MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
24.89MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-2.61MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-7.68MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-164.75MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-52.88MCNYFY2025 · Dec 31, 2025
Sale of Investments
52.95MCNYFY2025 · Dec 31, 2025
Other Investing Activity
2.96MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-161.71MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
328.72MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-276.77MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-19.87MCNYFY2025 · Dec 31, 2025
Other Financing Charges
182.79MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
214.87MCNYFY2025 · Dec 31, 2025
Shares Outstanding
100.71MSharesUpdated Oct 24, 2026
Float Shares
68.82MSharesUpdated Oct 24, 2026
% Held by Insiders
32.12%
vs all stocks
Updated Oct 24, 2026
% Held by Institutions
8.42%
vs all stocks
Updated Oct 24, 2026
Total Cash (MRQ)
244.30MCNY
36.64M · vs all stocks (USD)
Updated Oct 24, 2026
Total Cash per Share (MRQ)
2.43CNYUpdated Oct 24, 2026
Total Debt (MRQ)
542.65MCNY
81.39M · vs all stocks (USD)
Updated Oct 24, 2026
Total Debt to Equity (MRQ)
0.6690x
Updated Oct 24, 2026
Current Ratio (MRQ)
0.8190x
Updated Oct 24, 2026
Book Value per Share (MRQ)
7.66CNYUpdated Oct 24, 2026
Total Assets
1.92BCNY
288.09M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
730.14MCNYFY2025 · Dec 31, 2025
Total Liabilities
1.12BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.19BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
278.30MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
841.31MCNYFY2025 · Dec 31, 2025
Cash
295.85MCNYFY2025 · Dec 31, 2025
Cash Equivalents
16.57MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
312.42MCNYFY2025 · Dec 31, 2025
Accounts Receivable
192.53MCNYFY2025 · Dec 31, 2025
Inventory
108.46MCNYFY2025 · Dec 31, 2025
Accounts Payable
232.75MCNYFY2025 · Dec 31, 2025
Short-term Debt
374.26MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
198.70MCNYFY2025 · Dec 31, 2025
Long-term Debt
210.99MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
21.91MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
100.71MCNYFY2025 · Dec 31, 2025
Retained Earnings
67.10MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
801.24MCNY
120.17M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
14.65CNYUpdated Oct 24, 2026
52-Week High
34.34CNYUpdated Oct 24, 2026
52-Week Change
16.53%
vs all stocks
Updated Oct 24, 2026
Beta
0.1800x
vs all stocks
Updated Oct 24, 2026
50-Day MA
22.77CNYUpdated Oct 24, 2026
200-Day MA
23.13CNYUpdated Oct 24, 2026
Avg 10-Day Volume
10.22MSharesUpdated Oct 24, 2026
Avg 30-Day Volume
6.57MSharesUpdated Oct 24, 2026
Diluted EPS (TTM)
-0.4800CNYUpdated Oct 24, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.3: grey zoneSignificant
Altman Z-Score: 1.30
Supply Chain
Upstream position: supplies 5 industries, depends on 2Notable
Outgoing: 5.00Incoming: 2.00
Scale
Levered free cash flow is $19.24M, above the global median of $18.58MNotable